US pharmaceutical company Eli Lilly and Company reported its results today, which beat expectations and $LLY+0.2% shares are up more than 15% in response. Fundamentals are quite solid and the stock is up over 40% for the year, which I like and since I see potential in healthcare and I like pharmaceutical and medical companies, I like this company even more :D. The stock may be up, but so is the price. If I decided to buy this stock, I would buy at $370 and below.

How do you view this company and do you have $LLY+0.2% stock included in your portfolio?

LLY

Eli Lilly

LLY
$887.16 $1.61 +0.18%

In Patria's coverage, there's one more link "Unexpectedly good quarterly numbers came together today with results from Novo Nordisk's clinical trial for rival Wegova. As Mounjaro is based on a similar principle (GLP-1/GIP analogue), its indication is expected to be extended to cardiovascular disease in the future as well."

Don't have an account? Join us

Log in to Bulios


Sign.popup.orUseEmailAndPassword
Už jsi členem? Přihlásit se

Create Bulios profile

Continue with

Sign.popup.orUseEmailAndPassword
You can use lowercase letters, numbers, and underscores

Why Bulios?

One of the fastest growing investor communities in Europe

Comprehensive data and information on thousands of stocks from around the world

Current information from global markets and individual companies

sign.popup.registration.listWhy.fourth

Fair prices, portfolio tracker, stock screener and other tools

Timeline Tracker Overview